⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

Okayama Shoka University

h-index: 20
Total citations: 1,982
Total papers: 330

Homepage: http://www.osu.ac.jp/

Recent papers from Okayama Shoka University

Optimal Funded Pension for Consumers With Heterogeneous Self‐ControlJournal of Public Economic Theory · 2026
Abstract CT248: Zidesamtinib in patients with ROS1+ NSCLC previously treated with repotrectinib or taletrectinibCancer Research · 2026
Abstract 773: Single-cell and spatial transcriptomic profiling reveal fibrosis-related tumor states in lung squamous cell carcinoma associated with idiopathic pulmonary fibrosis.Cancer Research · 2026
Abstract 2906: The iRGD peptide reprograms the tumor microenvironment and potentiates immunotherapy in an advanced humanized PDAC mouse modelCancer Research · 2026
Abstract 3193: Secreted BRAF V600E drives ADAR1-dependent RNA editing and defines a therapeutic vulnerability in colorectal cancerCancer Research · 2026
Abstract 3544: Single-cell multi-omics uncovers coordinated epigenetic and transcriptomic evolution in IDH-mutant gliomaCancer Research · 2026
Why the Lewis turning point debate in China remains unsettled: a regional CES-based reassessmentApplied Economics Letters · 2026
Abstract PS2-08-27: Final Analysis of a Prospective Observational Study to Evaluate the Impact of Comprehensive Genome Profiling on Treatment Decision Making in Metastatic or Recurrent Breast Cancer in Japan: JBCRG-C07 REIWA StudyClinical Cancer Research · 2026
Abstract PS2-05-02: Feasibility of Tailored Axillary Surgery (TAS) in Patients with Clinically Node-Positive Breast Cancer in the Upfront Surgery Setting: Results of a Prospective, Single-Arm, Multicenter Phase II TrialClinical Cancer Research · 2026
Correction: Modular and chromatography-free synthesis of natural linear polyaminesOrganic & Biomolecular Chemistry · 2026
Modular and chromatography-free synthesis of natural linear polyaminesOrganic & Biomolecular Chemistry · 2025
Preliminary data from the Phase I/II study of nuvisertib, an oral investigational selective PIM1 inhibitor, in combination with momelotinib showed clinical responses in patients with relapsed/refractory myelofibrosisBlood · 2025
Progress in silicon-based materials for emerging solar-powered green hydrogen (H2) productionAdvances in Colloid and Interface Science · 2025
Unilateral Chasing and Courtship-Like Display as Dominance Signals for Hierarchy Maintenance in Male Medaka Fish2024
The Excess-Path-Length Distribution of Electrons in Electromagnetic Cascade ShowersProgress of Theoretical and Experimental Physics · 2024
Abstract 5271: Pseudohypoxia by HIF-PHD inhibitors activates tumor immune response for MSS colorectal cancerCancer Research · 2024
Abstract 7536: CD4+T cell exhaustion in the tumor microenvironment and antitumor immunityCancer Research · 2024
Abstract 6248: Multilayered molecular interactions underlying glioblastoma pathogenesis through multi-omics analysisCancer Research · 2024
Abstract 2897: Cancer associated fibroblasts targeted photoimmunotherapy improves drug deliveryCancer Research · 2024
Effectiveness of 1-year pemafibrate treatment on steatotic liver disease: the influence of alcohol consumptionEuropean Journal of Gastroenterology & Hepatology · 2024